Feng-Yen Li, a PhD candidate in biomedical sciences at UCSF, is among 13 graduate students from throughout North America chosen to receive the 2012 Harold M. Weintraub Graduate Student Award.
February 24, 2012
Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at UCSF have found — work that may improve the effectiveness of combination treatments that include drugs like Avastin.
February 22, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at UCSF have discovered how a protein “master regulator” goes awry, leading to metastasis, the fatal step of cancer.
February 06, 2012
A new UCSF analysis has found that a state ballot initiative to increase the cigarette tax would create about 12,000 jobs and nearly $2 billion in new economic activity in California.
February 03, 2012
In a triumph of the human spirit and life-saving health care, Angelica Galang, 23, is now attending law school after UCSF neurosurgeon Philip Weinstein removed a five-inch tumor in one of the most complex spinal surgeries of its kind.
February 01, 2012
Scientists at UCSF have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease.
January 26, 2012
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
January 17, 2012
Scientists from the University of Helsinki, Finland, and UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave. The discovery points to a new target for therapy.
December 23, 2011
A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.
December 12, 2011
UCSF Nobel laureate Elizabeth Blackburn, PhD, whose co-discovery of an enzyme involved in cell aging and cancers opened a whole new field of scientific inquiry, was inducted into the California Hall of Fame on Dec. 8, 2011.